Literature DB >> 11095646

Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis.

Stephan Segerer1, Yan Cui1, Kelly L Hudkins1, Tracy Goodpaster1, Frank Eitner2, Matthias Mack3, Detlef Schlöndorff3, Charles E Alpers1.   

Abstract

Crescents are morphologic manifestations of severe glomerular injury. Several chemokines and their receptors have been demonstrated to be involved in animal models of crescentic glomerulonephritis (cGN) and are potential targets for therapeutic interventions. Therefore, the expression of monocyte chemoattractant protein-1 (MCP-1), its receptor chemokine receptor 2B (CCR2B), and CCR5 in human cGN was studied. MCP-1 and CCR2B mRNA expression was evaluated, by in situ hybridization, in serial sections of 23 renal biopsies from patients with cGN. T cells, macrophages, and CCR5-expressing cells were examined by immunohistochemical analysis. MCP-1 mRNA was expressed by cells in crescents, parietal epithelium, and tubular epithelium, as well as by infiltrating leukocytes in the tubulointerstitium. The expression of CCR2B mRNA was observed in cells in glomeruli and crescents and in infiltrating leukocytes in the tubulointerstitium. CCR2B mRNA expression could not be clearly localized to intrinsic renal cells; evidence that most of the CCR2B-expressing cells were leukocytes is provided. CD3-positive T cells formed the major part of the interstitial cell infiltrates but were rare within the glomerular tufts. CD68-positive macrophages constituted a major population of infiltrating cells in crescents and contributed significantly to the interstitial infiltrates. The number of glomerular macrophages was associated with the number of MCP-1- and CCR2B-positive glomerular cells. Expression of CCR2B was significantly correlated with interstitial CD3-positive T cells. CCR5 expression was restricted to infiltrating leukocytes and was correlated quantitatively and by localization with interstitial CD3-positive T cells and CD68-positive macrophages. These first morphologic data on the distribution of CCR2-positive cells in human cGN suggest differential effects of chemokines and their receptors on the distribution of infiltrating leukocytes in different compartments of the kidney.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095646     DOI: 10.1681/ASN.V11122231

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

1.  Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.

Authors:  Maki Urushihara; Naro Ohashi; Kayoko Miyata; Ryousuke Satou; Omar W Acres; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

Review 2.  Strategies to optimize kidney recovery and preservation in transplantation: specific aspects in pediatric transplantation.

Authors:  Tackwa Khalifeh; Edouard Baulier; Sylvain Le Pape; Thomas Kerforne; Remy Coudroy; Souleymane Maiga; Thierry Hauet; Michel Pinsard; Frederic Favreau
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

3.  Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice.

Authors:  S Taneda; S Segerer; K L Hudkins; Y Cui; M Wen; M Segerer; M H Wener; C G Khairallah; A G Farr; C E Alpers
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

4.  Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2.

Authors:  Vijayashree Mysore; Suhail Tahir; Kazuhiro Furuhashi; Jatin Arora; Florencia Rosetti; Soumya Raychaudhuri; Bruce H Horwitz; Xavier Cullere; Pascal Yazbeck; Miroslav Sekulic; Madeleine E Lemieux; Tanya N Mayadas
Journal:  J Exp Med       Date:  2022-04-11       Impact factor: 14.307

Review 5.  The emergence of the glomerular parietal epithelial cell.

Authors:  Stuart J Shankland; Bart Smeets; Jeffrey W Pippin; Marcus J Moeller
Journal:  Nat Rev Nephrol       Date:  2014-01-28       Impact factor: 28.314

6.  Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis.

Authors:  L M McIntosh; J L Barnes; V L Barnes; J R McDonald
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

7.  CCL2 mediates early renal leukocyte infiltration during salt-sensitive hypertension.

Authors:  Ammar J Alsheikh; John Henry Dasinger; Justine M Abais-Battad; Daniel J Fehrenbach; Chun Yang; Allen W Cowley; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2020-03-09

8.  CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.

Authors:  Julia Menke; Geraldine C Zeller; Eriya Kikawada; Terry K Means; Xiao R Huang; Han Y Lan; Bao Lu; Joshua Farber; Andrew D Luster; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

Review 9.  [CCL2/MCP1: a novel target in systemic lupus erythematosus and lupus nephritis].

Authors:  O Kulkarni; H-J Anders
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

10.  Blockade of CCR2 ameliorates progressive fibrosis in kidney.

Authors:  Kiyoki Kitagawa; Takashi Wada; Kengo Furuichi; Hiroyuki Hashimoto; Yoshiro Ishiwata; Masahide Asano; Motohiro Takeya; William A Kuziel; Kouji Matsushima; Naofumi Mukaida; Hitoshi Yokoyama
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.